文献速递细胞病理与分子病理乳腺病理

国际细胞学会横滨乳腺细胞病理报告系统提高诊断准确性

The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy.
PubMed 文献 · Cancer Cytopathol · 2021-05-24

本研究回顾16年间1080例乳腺细针穿刺活检病例,按国际细胞学会横滨报告系统重新分类并与原诊断比较。系统应用后诊断性能显著提高(P < .001),中间经验病理医师与专家诊断一致性高于经验短者(κ 0.838 vs 0.634)。

要点

  • 系统分类分布:不足11.7%、良性56.6%、非典型20.1%、可疑恶性6.1%、恶性5.6%。
  • 不足和非典型类别比例低于原诊断(13.1%和23.8%)。
  • 中间经验病理医师与专家一致性κ为0.838,经验短者为0.634。

核心结论

  • 横滨系统有效分类乳腺FNAB诊断并提高诊断性能。
  • 结构化报告增强中间经验病理医师报告的可重复性,对经验短者也有一定作用。

研究设计与样本

  • 回顾性研究,纳入16年间1080例乳腺细针穿刺活检病例,按横滨系统重新分类并与原诊断比较。

主要发现

  • 系统分类分布:不足11.7%、良性56.6%、非典型20.1%、可疑恶性6.1%、恶性5.6%。
  • 不足和非典型类别比例低于原诊断率(13.1%和23.8%)。
  • 共120例(11.1%)被重新分类;其中重新分类为良性、可疑或恶性且有随访数据的病例中96.7%正确重分类。
  • 系统应用后诊断性能显著改善(P < .001),在纤维上皮病变、乳头状病变和低级别癌中亦见改善。
  • 中间经验病理医师与专家诊断一致性κ为0.838,高于经验短者的0.634。

临床怎么用

  • 采用横滨系统对乳腺FNAB进行结构化报告,可提高诊断准确性和不同经验病理医师间的一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology is to improve cytology practice. This study assessed cytologic diagnoses made with the system and its efficacy when it was applied by pathologists with different levels of experience. METHODS: In all, 1080 cases of breast fine-needle aspiration biopsy (FNAB) over a period of 16 years were reviewed and reclassified with the system. The category distribution and the diagnostic performance were compared with the original diagnoses. The concordance rates for diagnoses from pathologists with different levels of experience were also determined. RESULTS: The distribution of cytologic diagnoses made with the system was as follows: 11.7% were insufficient, 56.6% were benign, 20.1% were atypical, 6.1% were suspicious for malignancy, and 5.6% were malignant. The rates for the insufficient and atypical categories were lower than the original diagnosis rates (13.1% and 23.8%, respectively). Overall, 120 cases (11.1%) were recategorized. Among those recategorized as benign, suspicious, or malignant with follow-up data, 96.7% were correctly reclassified. A significant improvement in diagnostic performance was found with the system (P < .001). Such improvement was also seen in problematic breast lesions, including fibroepithelial lesions, papillary lesions, and low-grade carcinomas. Pathologists with intermediate experience showed a higher concordance with an expert pathologist in the diagnoses than those with short experience (κ, 0.838 vs 0.634). CONCLUSIONS: The system effectively categorized the diagnoses, and the diagnostic performance of FNAB reporting was improved. The structured reporting also enhanced the reproducibility of reporting by pathologists with intermediate experience and, to some extent, those with short experience.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Marabi M, Aphivatanasiri C, Jamidi SK, et al. The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy. Cancer Cytopathol. 2021. PMID: 34029453. doi:10.1002/cncy.22451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。